Point72 Hong Kong’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
BBA
CS
FLSM
Point72 Hong Kong's BLUE Position: Q4 2022 in Review
Point72 Hong Kong sold out of bluebird bio (BLUE) in Q4 2022, closing a stake of 2,607 shares — an estimated $330K sold.
Point72 Hong Kong first reported a position in BLUE in Q4 2015 and held it in 17 quarters. The position peaked at $1.04M in Q2 2020. 184 funds tracked by Wall St. Rank hold BLUE as of Q4 2022.
- Point72 Hong Kong reported no remaining bluebird bio position as of Q4 2022 after selling out during the quarter.
- Point72 Hong Kong sold 2,607 bluebird bio shares in Q4 2022, an estimated $330K.
- Point72 Hong Kong first reported a position in bluebird bio in Q4 2015 and held it in 17 quarters.
- Point72 Hong Kong's bluebird bio position peaked at $1.04M in Q2 2020.
- 184 funds tracked by Wall St. Rank held bluebird bio as of Q4 2022.
Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.